Novartis Aktie
99,44
EUR
+0,78
EUR
+0,79
%
92,46
CHF
-0,18
CHF
-0,19
%
Werbung
Novartis Aktie Analyse
09.01.17 | Novartis Hold | Deutsche Bank AG | |
03.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
13.12.16 | Novartis Hold | Deutsche Bank AG | |
08.12.16 | Novartis Neutral | UBS AG | |
30.11.16 | Novartis Hold | Deutsche Bank AG | |
26.10.16 | Novartis Hold | Deutsche Bank AG | |
25.10.16 | Novartis Hold | S&P Capital IQ | |
19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
Werbung
|
|||
14.10.16 | Novartis Hold | Deutsche Bank AG | |
10.10.16 | Novartis Hold | Deutsche Bank AG | |
10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
14.09.16 | Novartis Neutral | BNP PARIBAS | |
04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
20.07.16 | Novartis Neutral | UBS AG | |
20.07.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.07.16 | Novartis Halten | Independent Research GmbH | |
06.07.16 | Novartis Halten | Independent Research GmbH | |
23.06.16 | Novartis Hold | Deutsche Bank AG | |
23.05.16 | Novartis Neutral | Citigroup Corp. | |
19.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
18.05.16 | Novartis Neutral | Citigroup Corp. | |
09.05.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
28.04.16 | Novartis Neutral | UBS AG | |
26.04.16 | Novartis Neutral | BNP PARIBAS | |
22.04.16 | Novartis Equal weight | Barclays Capital | |
19.04.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
15.04.16 | Novartis Neutral | UBS AG | |
06.04.16 | Novartis Hold | Société Générale Group S.A. (SG) | |
01.04.16 | Novartis Neutral | UBS AG | |
29.03.16 | Novartis Neutral | Citigroup Corp. | |
17.02.16 | Novartis Halten | Independent Research GmbH | |
28.01.16 | Novartis Hold | S&P Capital IQ | |
28.01.16 | Novartis Neutral | BNP PARIBAS | |
28.01.16 | Novartis Halten | Independent Research GmbH | |
28.01.16 | Novartis Hold | Société Générale Group S.A. (SG) | |
13.01.16 | Novartis Halten | Independent Research GmbH | |
08.01.16 | Novartis Hold | Deutsche Bank AG | |
07.01.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
02.12.15 | Novartis Equal-Weight | Morgan Stanley | |
30.11.15 | Novartis Hold | Deutsche Bank AG | |
25.11.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
11.11.15 | Novartis neutral | Morgan Stanley | |
28.10.15 | Novartis Halten | Independent Research GmbH | |
28.10.15 | Novartis Hold | Deutsche Bank AG | |
28.10.15 | Novartis Equal weight | Barclays Capital | |
28.10.15 | Novartis Hold | Société Générale Group S.A. (SG) | |
27.10.15 | Novartis Hold | S&P Capital IQ | |
21.10.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
03.09.15 | Novartis Halten | Independent Research GmbH | |
27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. |
Werbung
Werbung